跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Octritide - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Octritide
Approved
STANDARD
Octritide
Beijing SL Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
06af39a7d605c379
Company
Beijing SL Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
06af39a7d605c379
Drug Approval Philippines Name
Octritide
Product Name
Octritide
Registration Number
DRP-6961
Brand Name
Octritide
Generic Name
Octreotide Acetate
Dosage Form
Solution for Injection (SC/IV)
Dosage Strength
100 mcg/mL
Manufacturer
Beijing SL Pharmaceutical Co., Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Company Detail Path
/organization/beijing-sl-pharmaceutical-co-ltd
Issuance Date
27 September 2021
Expiry Date
16 December 2026
Pharmacologic Category
Somatostatin analogue
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
06af39a7d605c379
Type
Standard
Back to Philippines FDA Approvals